Can antiplatelet therapy after drug eluting stent become a problem?
DOI: https://doi.org/10.7175/cmi.v3i1.556
Abstract
Many clinical trials demonstrate that demonstrate drug-eluting stents (DES) can improve procedural success in patients with acute coronary syndromes, with a remarkable reduction in the rate of restenosis. On the other hand, it has been shown that stenting can also increase the rate of thrombotic complications including stent thrombosis. We describe a case of a 62-yaers-old male with angina. Four weeks after the insertion of a drug-eluting stent, the patients was admitted to our Emergency Department with asthenia.
Keywords
Drug-eluting stent; Coronary syndromes; Antiplatelet therapy
Full Text
Statistics
Abstract: 808 viewsPDF: 2070 views
Refbacks
- There are currently no refbacks.